Euroapi S.A. (OTCMKTS:EAPIF – Get Free Report) was the target of a large decrease in short interest in October. As of October 30th, there was short interest totaling 1,228 shares, a decrease of 95.6% from the October 15th total of 28,026 shares. Based on an average daily trading volume, of 493 shares, the short-interest ratio is currently 2.5 days.
Euroapi Price Performance
Shares of OTCMKTS EAPIF remained flat at C$0.89 during mid-day trading on Thursday. 132 shares of the company were exchanged, compared to its average volume of 1,659. The stock has a 50-day simple moving average of C$0.95 and a 200 day simple moving average of C$1.46. Euroapi has a 1 year low of C$0.84 and a 1 year high of C$3.46.
Euroapi Company Profile
Euroapi is a pharmaceutical ingredients company headquartered in France. It develops and manufactures active pharmaceutical ingredients (APIs), the substances that provide the therapeutic effect in medicines, and supplies them to pharmaceutical companies and other customers. The company offers a range of APIs as well as contract development and manufacturing services. Its work can support customers through different stages of product development and commercial production, including the manufacture of ingredients to customer specifications.
Featured Stories
- Five stocks we like better than Euroapi
- Tesla’s Plan to End Cybertruck Reveals Its Real Priorities
- The Post-Midterm Rally Clock Is Ticking—and These 3 AI Stocks Stand Out
- Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-Off
- Palantir’s Real Washington Risk Isn’t the Budget—It’s Oversight
Receive News & Ratings for Euroapi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Euroapi and related companies with MarketBeat.com's FREE daily email newsletter.
